Department Administrator
About the job
- A Bachelor's degree or equivalent experience is required.
- Five to ten years of executive administrative support experience is required, preferably supporting senior leaders in a global environment.
- Strong proficiency in Microsoft 365, including Outlook, Teams, PowerPoint, Excel, and Word, is required.
- Excellent written and verbal communication skills are required.
- Strong organizational, planning, and multitasking abilities are required.
- The ability to handle confidential information with discretion is required.
- Proactively manage the AVP-GSCS calendar and schedules, coordinate meeting logistics, and organize recurring internal staff meetings and management-level monthly reviews.
- Maintain awareness of significant deadlines and plan proactively for them.
- Coordinate travel arrangements, including booking flights, processing Concur expense claims, arranging hotels and local transportation, preparing agendas and itineraries, and arranging visa and passport requirements as needed.
- Plan and manage quarterly webcasts and assist with developing content and slides.
- Coordinate logistics, agendas, and minutes for quarterly webcasts, town halls, business review meetings, staff meetings, and monthly meetings.
- Communicate professionally with internal customers, external suppliers, executives, and employees at all levels of the company.
- Participate in and lead projects within the function as needed.
- Manage the SharePoint database.
- Maintain and update organization charts on internal G sites.
- Act as an execution partner to the GSCS leadership team by coordinating priorities and ensuring a smooth operational rhythm.
- Anticipate administrative needs and proactively resolve issues.
- Support strategic priorities through effective planning and follow-up.
- Handle sensitive organizational and personnel information confidentially.
- Experience supporting global operations, supply chain, manufacturing, or technology organizations is preferred.
About the company
Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.
Company Size
10,001+
Company Stage
IPO
Headquarters
Santa Clara, California
Founded
1999
Get referred to Agilent Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q3 FY2026 revenue hit $1.88 billion, up 8.1%, and guidance rose to $7.51 billion.
- China grew 9% and pharma grew 12%, signaling stronger end markets.
- September 2026 launches, including S540MD and Gen5 AI, expand higher-value digital pathology.
What critics are saying
- Tariff refunds added 110 basis points to Q3 margin, masking underlying profitability.
- FY26 restructuring costs and workforce reductions continue through first-quarter 2027.
- A failed pathology pivot leaves Agilent overexposed to slower instrument cycles and commoditization.
What makes Agilent Technologies unique
- Agilent combines instruments, software, and consumables across pathology, imaging, and analytics.
- The June 2026 Biocare Medical acquisition deepens its pathology menu and clinical reach.
- June 2026 OpenAI and BCG collaboration pushes AI into products, operations, and workflows.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Performance Bonus
Stock Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -3%Agilent Technologies has launched the BioTek Gen5 AI cell identification module, a new image analysis software add-on for its BioTek automated imaging systems. The module uses AI-based cell identification and segmentation, eliminating the need for conventional threshold setting or parameter tuning. The technology addresses challenges researchers face with threshold-based segmentation, which requires establishing and optimising analysis parameters for individual experiments. This process can introduce user-dependent variation and create difficulties in high-throughput imaging workflows. The module supports label-free and fluorescence applications, as well as live-cell and kinetic assays commonly used in life science and pharmaceutical research. It integrates with Gen5 software, allowing researchers using compatible BioTek Cytation and Lionheart automated imagers to apply AI-based segmentation within existing workflows. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.
Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.
Agilent Technologies announced that Koh Boon Hwee retired from its board of directors on 4 September 2026, after more than 20 years of service. Koh joined the board in 2003 and served as independent chair from 2017 until his retirement. Dow R. Wilson, a board member since 2018, was elected as the new chair. Wilson currently chairs the Audit and Finance Committee. The company also appointed Glenn Boehnlein to its board, effective 4 September 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement in 2025. He currently serves on the boards of Inogen and Sutter Health.
Agilent Technologies has launched the Cary 635 FTIR spectrometer, described as the smallest Fourier transform infrared analyser in its class. The compact instrument combines high-performance analysis with user-friendly operation, requiring minimal technical training. The spectrometer features solid ZnSe optical components for enhanced moisture resistance and improved sensitivity for analysing lower-concentration samples. Its modular architecture supports analysis of solids, liquids, powders, and gases, whilst permanently aligned optics enable rapid interchange of sampling modules. The device includes MicroLab software with step-by-step workflows and colour-coded results, allowing novice users to be trained quickly. Agilent generated $6.95 billion in revenue during fiscal year 2025 and employs approximately 18,000 people worldwide.
Agilent Technologies reported fiscal third-quarter revenue of $1.88 billion, up 8.1% year-over-year. Core revenue, excluding currency movements and M&A activity, grew 7.3%. The company's non-GAAP operating margin reached 28.3%, expanding 320 basis points. However, roughly 110 basis points of that improvement stemmed from tariff refunds, which also added $17 million to non-GAAP net income and approximately $0.06 to earnings per share. Excluding the refunds, operating margin expansion was approximately 210 basis points, supported by higher revenue and operational efficiencies. All three business segments reported revenue growth, with Life Sciences and Diagnostics Markets Group up 11%, CrossLab up 6%, and Applied Markets up 7%. For the full year, Agilent expects non-GAAP operating margin expansion of more than 130 basis points, including roughly 30 basis points from the tariff refunds.